IL84154A0 - Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same - Google Patents
Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the sameInfo
- Publication number
- IL84154A0 IL84154A0 IL84154A IL8415487A IL84154A0 IL 84154 A0 IL84154 A0 IL 84154A0 IL 84154 A IL84154 A IL 84154A IL 8415487 A IL8415487 A IL 8415487A IL 84154 A0 IL84154 A0 IL 84154A0
- Authority
- IL
- Israel
- Prior art keywords
- immunodeficiency virus
- insect cells
- human immunodeficiency
- same
- immune deficiency
- Prior art date
Links
- 208000030507 AIDS Diseases 0.000 title 1
- 241000238631 Hexapoda Species 0.000 title 1
- 241000725303 Human immunodeficiency virus Species 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 208000011580 syndromic disease Diseases 0.000 title 1
- 241000701447 unidentified baculovirus Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
- C12N2810/6045—RNA rev transcr viruses
- C12N2810/6054—Retroviridae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/60—Vector systems having a special element relevant for transcription from viruses
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92019786A | 1986-10-16 | 1986-10-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL84154A0 true IL84154A0 (en) | 1988-03-31 |
Family
ID=25443341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL84154A IL84154A0 (en) | 1986-10-16 | 1987-10-13 | Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0265785A3 (xx) |
JP (1) | JPS63207397A (xx) |
CN (1) | CN87107837A (xx) |
AR (1) | AR241940A1 (xx) |
AU (2) | AU7984287A (xx) |
BR (1) | BR8705535A (xx) |
DD (3) | DD283935A5 (xx) |
DK (1) | DK541987A (xx) |
FI (1) | FI874564A (xx) |
HU (1) | HUT45095A (xx) |
IE (1) | IE872748L (xx) |
IL (1) | IL84154A0 (xx) |
LT (3) | LTIP1793A (xx) |
LV (1) | LV10654B (xx) |
PL (2) | PL161165B1 (xx) |
ZA (1) | ZA877752B (xx) |
Families Citing this family (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63258575A (ja) * | 1986-12-15 | 1988-10-26 | レプリゲン コーポレーション | 昆虫細胞中でつくられる組換えhivエンベロープタンパク |
IL85149A0 (en) * | 1987-01-27 | 1988-06-30 | Microgenesys Inc | Hiv gp160 aids virus envelope protein-containing substrates and methods for detection of aids antibody thereby |
US5681713A (en) * | 1987-05-08 | 1997-10-28 | Smithkline Beecham Corporation | Expression of heterologous proteins in Drosophila cells |
IL89118A0 (en) * | 1988-02-03 | 1989-08-15 | Microgenesys Inc | Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1 |
IL90048A0 (en) * | 1988-04-25 | 1989-12-15 | Merck & Co Inc | Recombinant gag precursor of hiv,its preparation and its use as aids vaccine |
JP2511494B2 (ja) * | 1988-05-12 | 1996-06-26 | 善治 松浦 | 日本脳炎ウイルス表面抗原蛋白質の製造法 |
CA2003300A1 (en) * | 1988-11-21 | 1990-05-21 | Franklin Volvovitz | Skin test and test kit for aids |
JP2852431B2 (ja) * | 1988-12-07 | 1999-02-03 | 財団法人阪大微生物病研究会 | レトロウイルスのプロテアーゼ、逆転写酵素及びエンドヌクレアーゼ、並びにこれ等の酵素の製法 |
US5858646A (en) * | 1989-02-23 | 1999-01-12 | University Of Ottawa | Modified HIV-pol polypeptide having immunological activity for use as diagnostic reagent |
WO1990010078A1 (en) * | 1989-02-23 | 1990-09-07 | University Of Ottawa | Improved baculovirus expression system capable of producing foreign gene proteins at high levels |
US5194376A (en) * | 1989-02-28 | 1993-03-16 | University Of Ottawa | Baculovirus expression system capable of producing foreign gene proteins at high levels |
EP0385909B1 (en) * | 1989-03-03 | 1994-07-13 | MicroGeneSys, Inc. | A kit or composition for the prevention or treatment of HIV-1 infections |
DE69019609T2 (de) * | 1989-07-07 | 1995-11-30 | Takeda Chemical Industries Ltd | Proteine und deren Herstellung. |
EP0421626A1 (en) * | 1989-09-19 | 1991-04-10 | Merck & Co. Inc. | Vaccine for aids and hepatitis B |
US5346989A (en) * | 1990-08-22 | 1994-09-13 | Syntello Vaccine Development Kb | Peptides for use in induction of T cell activation against HIV-1 |
ES2108872T3 (es) * | 1992-04-24 | 1998-01-01 | Us Gov Health & Human Serv | Deteccion de anticuerpos especificos del virus del sarampion por medio de las proteinas recombinantes del sarampion. |
DE4405810A1 (de) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
JP2002512501A (ja) | 1996-07-03 | 2002-04-23 | メリアル インコーポレイテッド | 外来性dnaを含む組換えイヌアデノウィルス(cav) |
US6517843B1 (en) | 1999-08-31 | 2003-02-11 | Merial | Reduction of porcine circovirus-2 viral load with inactivated PCV-2 |
US6224882B1 (en) | 1997-11-07 | 2001-05-01 | Protein Science Corp. | Insect cells or fractions as adjuvant for antigens |
JP2002030098A (ja) * | 2000-07-17 | 2002-01-29 | Institute Of Immunology Co Ltd | バキュロウィルスの発芽ウイルスからウイルスエンベロープを回収する方法 |
MXPA05003049A (es) | 2002-09-19 | 2005-11-17 | Us Gov Health & Human Serv | Polipeptidos de phlebotomus ariasi, polipeptidos de phlebotomus perniciosus y metodos de uso. |
EP1572968B1 (en) | 2002-10-29 | 2009-04-22 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Lutzomyia longipalpis polypeptides and methods of use |
EP2390352A1 (en) | 2003-03-18 | 2011-11-30 | Quantum Genetics Ireland Limited | Systems and methods for improving protein and milk production of dairy herds |
US7468273B2 (en) | 2003-05-01 | 2008-12-23 | Meial Limited | Canine GHRH gene, polypeptides and methods of use |
US7786288B2 (en) * | 2003-10-23 | 2010-08-31 | Karp Nelson M | Immunizing compositions encoding an epitope obtained from the HIV-1 capsid protein cyclophilin A binding site |
ES2417019T3 (es) | 2003-11-13 | 2013-08-05 | University Of Georgia Research Foundation, Inc. | Procedimiento de caracterización del virus de la enfermedad de la bursitis infecciosa |
US20050202484A1 (en) | 2004-02-19 | 2005-09-15 | The Governors Of The University Of Alberta | Leptin promoter polymorphisms and uses thereof |
RS51324B (sr) | 2005-04-25 | 2010-12-31 | Merial Ltd. | Vakcine protiv nipah virusa |
US20080241184A1 (en) | 2005-08-25 | 2008-10-02 | Jules Maarten Minke | Canine influenza vaccines |
US7771995B2 (en) | 2005-11-14 | 2010-08-10 | Merial Limited | Plasmid encoding human BMP-7 |
US7598364B2 (en) | 2005-11-14 | 2009-10-06 | Merial Limited | Plasmid encoding canine BMP-7 |
US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
GB2440528A (en) * | 2006-07-27 | 2008-02-06 | Ist Superiore Sanita | Antigen-antibody complexes |
US8202967B2 (en) | 2006-10-27 | 2012-06-19 | Boehringer Ingelheim Vetmedica, Inc. | H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
ES2825718T3 (es) * | 2007-02-01 | 2021-05-17 | Univ Der Johannes Gutenberg Univ Mainz | Activación específica de una célula T reguladora y su uso para el tratamiento del asma, enfermedades alérgicas, enfermedades autoinmunes, rechazo de injertos y para la inducción de tolerancia |
WO2009088256A2 (ko) * | 2008-01-09 | 2009-07-16 | Konkuk University Industrial Cooperation Corp | 배큘로바이러스-기반 백신 |
EP2283035B1 (en) | 2008-05-08 | 2015-07-29 | Merial Limited | Leishmania vaccine using sand fly salivary immunogen |
CN102428099B (zh) | 2009-04-03 | 2016-03-16 | 梅里亚有限公司 | 运载新城疫病毒的禽疫苗 |
AR078253A1 (es) | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad |
AU2011230619C1 (en) | 2010-03-25 | 2016-06-23 | Oregon Health & Science University | CMV glycoproteins and recombinant vectors |
JP5913316B2 (ja) | 2010-08-31 | 2016-04-27 | メリアル リミテッド | ニューカッスル病ウイルスをベクターとするヘルペスウイルスワクチン |
AR083533A1 (es) | 2010-10-22 | 2013-03-06 | Boehringer Ingelheim Vetmed | Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe |
WO2012090073A2 (en) | 2010-12-30 | 2012-07-05 | The Netherlands Cancer Institute | Methods and compositions for predicting chemotherapy sensitivity |
US20140287931A1 (en) | 2011-04-04 | 2014-09-25 | Stichting Het Nederlands Kanker Instituut - Antoni Van Leeuwenhoek Ziekenhuis | Methods and compositions for predicting resistance to anticancer treatment |
US20140296248A1 (en) | 2011-04-04 | 2014-10-02 | Stichting het Nederlands Kanker Instiuut-Antoni van Leeuwenhoek ziekenhuis | Methods and compositions for predicting resistance to anticancer treatment |
US9216213B2 (en) | 2011-04-20 | 2015-12-22 | Merial, Inc. | Adjuvanted rabies vaccine with improved viscosity profile |
AP2013007180A0 (en) | 2011-04-25 | 2013-10-31 | Advanced Bioscience Lab Inc | Truncated HIV envelope proteins (ENV), methods andcompositions related thereto |
CA2837375C (en) | 2011-06-01 | 2019-07-16 | Merial Limited | Needle-free administration of prrsv vaccines |
LT2691530T (lt) | 2011-06-10 | 2018-08-10 | Oregon Health & Science University | Cmv glikoproteinai ir rekombinantiniai vektoriai |
LT2734230T (lt) | 2011-07-20 | 2019-03-25 | Merial Limited | Rekombinantinė kačių leikemijos viruso vakcina, turinti optimizuotą kačių leukemijos viruso apvalkalo geną |
US10166188B2 (en) | 2011-08-12 | 2019-01-01 | Merial, Inc. | Method for vacuum-assisted preservation of biologics including vaccines |
AR088028A1 (es) | 2011-08-15 | 2014-05-07 | Boehringer Ingelheim Vetmed | Proteinas h5, de h5n1 para un uso medicinal |
WO2013033092A2 (en) | 2011-09-03 | 2013-03-07 | Boehringer Ingelheim Vetmedica Gmbh | Streptococcus suis pilus antigens |
WO2013093629A2 (en) | 2011-12-20 | 2013-06-27 | Netherlands Cancer Institute | Modular vaccines, methods and compositions related thereto |
WO2013138776A1 (en) | 2012-03-16 | 2013-09-19 | Merial Limited | Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g |
CA2867893C (en) | 2012-03-20 | 2022-09-20 | Merial Limited | Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof |
ES2689878T3 (es) | 2013-02-21 | 2018-11-16 | Boehringer Ingelheim Vetmedica Gmbh | Proteínas H5 del virus de la gripe H5N1 para su uso como un medicamento |
US9556419B2 (en) | 2013-03-12 | 2017-01-31 | Merial Inc. | Reverse genetics Schmallenberg virus vaccine compositions, and methods of use thereof |
JP6395855B2 (ja) | 2014-04-03 | 2018-09-26 | ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド | ブタ流行性下痢ウイルスワクチン |
WO2016073410A1 (en) | 2014-11-03 | 2016-05-12 | Merial, Inc. | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus |
BR112017027895A2 (pt) | 2015-06-23 | 2018-11-06 | Merial Inc | vetores virais recombinantes contendo proteínas menores de prrsv e métodos de fabricação e utilização destes |
KR20180042167A (ko) | 2015-08-31 | 2018-04-25 | 베링거잉겔하임베트메디카게엠베하 | 선천성 진전을 위한 페스티바이러스 백신 |
US20170072042A1 (en) | 2015-09-16 | 2017-03-16 | Boehringer Ingelheim Vetmedica, Inc. | Salmonella choleraesuis-salmonella typhimurium vaccines |
UY37406A (es) | 2016-09-20 | 2018-03-23 | Boehringer Ingelheim Vetmedica Gmbh | Nuevo sitio de inserción orf70 de ehv |
MX2019003158A (es) | 2016-09-20 | 2019-05-27 | Boehringer Ingelheim Vetmedica Gmbh | Vectores de adenovirus canino. |
MX2019003160A (es) | 2016-09-20 | 2019-05-27 | Boehringer Ingelheim Vetmedica Gmbh | Nuevos promotores. |
MX2019003116A (es) | 2016-09-20 | 2019-08-29 | Boehringer Ingelheim Vetmedica Gmbh | Nueva vacuna contra la gripe porcina. |
UA127859C2 (uk) | 2016-11-03 | 2024-01-31 | Бьорінгер Інгельхайм Ветмедіка Гмбх | Вакцина проти свинячого парвовірусу |
PT3534939T (pt) | 2016-11-03 | 2023-04-20 | Boehringer Ingelheim Vetmedica Gmbh | Vacina contra parvovírus porcino e vírus da síndrome reprodutiva e respiratória porcina e métodos da sua produção |
CA3046684A1 (en) | 2017-01-30 | 2018-08-02 | Boehringer Ingelheim Animal Health USA Inc. | Porcine coronavirus vaccines |
CN110869047A (zh) | 2017-07-12 | 2020-03-06 | 勃林格殷格翰动物保健美国有限公司 | 塞内卡病毒a免疫原性组合物及其方法 |
AU2018335252A1 (en) | 2017-09-23 | 2020-02-27 | Boehringer Ingelheim Vetmedica Gmbh | Paramyxoviridae expression system |
WO2019092027A1 (en) | 2017-11-09 | 2019-05-16 | Boehringer Ingelheim Vetmedica Gmbh | Sapelovirus immunogenic compositions and uses thereof |
EP3668988A1 (en) | 2018-02-23 | 2020-06-24 | Boehringer Ingelheim Vetmedica GmbH | Recombinant viral vector systems expressing exogenous feline paramyxovirus genes and vaccines made therefrom |
WO2019179998A1 (en) | 2018-03-19 | 2019-09-26 | Boehringer Ingelheim Vetmedica Gmbh | New ehv with inactivated ul18 and/or ul8 |
EA202092165A1 (ru) | 2018-03-19 | 2021-02-25 | Бёрингер Ингельхайм Ветмедика Гмбх | Новый ehv сайт инсерции ul43 |
CA3091982A1 (en) | 2018-03-26 | 2019-10-03 | Boehringer Ingelheim Animal Health USA Inc. | Method of producing an immunogenic composition |
KR20210062015A (ko) | 2018-09-20 | 2021-05-28 | 베링거잉겔하임베트메디카게엠베하 | 변형된 pedv 스파이크 단백질 |
US10905758B2 (en) | 2018-09-20 | 2021-02-02 | Boehringer Ingelheim Vetmedica Gmbh | Intranasal vector vaccine against porcine epidemic diarrhea |
CN115768784A (zh) | 2020-02-06 | 2023-03-07 | 勃林格殷格翰动物保健有限公司 | 用于检测抗弹状病毒抗体的多肽 |
CN116438202A (zh) | 2020-10-05 | 2023-07-14 | 勃林格殷格翰动物保健美国有限公司 | 包含圆环病毒科衣壳蛋白的融合蛋白及其构成的嵌合病毒样颗粒 |
TW202229314A (zh) | 2020-10-05 | 2022-08-01 | 德商百靈佳殷格翰維美迪加股份有限公司 | 用於針對輪狀病毒疫苗接種之融合蛋白質 |
WO2023194913A1 (en) | 2022-04-05 | 2023-10-12 | Boehringer Ingelheim Vetmedica Gmbh | Immunogenic composition useful for vaccination against rotavirus |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3485810T2 (de) * | 1983-05-27 | 1992-12-10 | Texas A & M University Syst | Verfahren zur herstellung eines rekombinanten baculovirus-expressionsvektors. |
NZ217645A (en) * | 1985-09-25 | 1991-11-26 | Oncogen | Recombinant viruses expressing lav/htlv-iii related epitopes and vaccine formulations |
ZA867281B (en) * | 1985-09-25 | 1987-05-27 | Oncogen | Vaccines and immunoassays for acquired immune deficiency syndrome |
JPS63167797A (ja) * | 1985-12-18 | 1988-07-11 | マイクロジエネシス,インコ−ポレイテイド | 選択された昆虫宿主細胞中で選択されたポリペプチドを製造する方法 |
JPS63258575A (ja) * | 1986-12-15 | 1988-10-26 | レプリゲン コーポレーション | 昆虫細胞中でつくられる組換えhivエンベロープタンパク |
-
1987
- 1987-10-13 IE IE872748A patent/IE872748L/xx unknown
- 1987-10-13 IL IL84154A patent/IL84154A0/xx unknown
- 1987-10-15 EP EP87115085A patent/EP0265785A3/en not_active Withdrawn
- 1987-10-15 ZA ZA877752A patent/ZA877752B/xx unknown
- 1987-10-16 HU HU874666A patent/HUT45095A/hu unknown
- 1987-10-16 DD DD87329440A patent/DD283935A5/de not_active IP Right Cessation
- 1987-10-16 DD DD30803987A patent/DD269629A5/de not_active IP Right Cessation
- 1987-10-16 JP JP62262572A patent/JPS63207397A/ja active Pending
- 1987-10-16 PL PL1987268266A patent/PL161165B1/pl unknown
- 1987-10-16 AU AU79842/87A patent/AU7984287A/en not_active Abandoned
- 1987-10-16 PL PL1987293520A patent/PL161448B1/pl unknown
- 1987-10-16 AR AR87308981A patent/AR241940A1/es active
- 1987-10-16 BR BR8705535A patent/BR8705535A/pt unknown
- 1987-10-16 CN CN198787107837A patent/CN87107837A/zh active Pending
- 1987-10-16 DK DK541987A patent/DK541987A/da not_active Application Discontinuation
- 1987-10-16 FI FI874564A patent/FI874564A/fi not_active IP Right Cessation
- 1987-10-16 DD DD87329441A patent/DD284046A5/de not_active IP Right Cessation
-
1991
- 1991-11-29 AU AU88324/91A patent/AU8832491A/en not_active Abandoned
-
1993
- 1993-05-14 LV LVP-93-344A patent/LV10654B/xx unknown
-
1994
- 1994-01-24 LT LTIP1793A patent/LTIP1793A/xx not_active Application Discontinuation
- 1994-01-24 LT LTIP1792A patent/LTIP1792A/xx unknown
- 1994-01-24 LT LTIP1794A patent/LTIP1794A/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPS63207397A (ja) | 1988-08-26 |
AU7984287A (en) | 1988-04-21 |
HUT45095A (en) | 1988-05-30 |
LTIP1793A (en) | 1995-08-25 |
BR8705535A (pt) | 1988-05-24 |
AR241940A1 (es) | 1993-01-29 |
LV10654A (lv) | 1995-04-20 |
DD284046A5 (de) | 1990-10-31 |
PL268266A1 (en) | 1988-08-18 |
FI874564A (fi) | 1988-04-17 |
DD283935A5 (de) | 1990-10-31 |
LTIP1792A (en) | 1995-08-25 |
ZA877752B (en) | 1989-06-28 |
EP0265785A2 (en) | 1988-05-04 |
DK541987D0 (da) | 1987-10-16 |
DD269629A5 (de) | 1989-07-05 |
FI874564A0 (fi) | 1987-10-16 |
IE872748L (en) | 1988-04-16 |
LV10654B (en) | 1995-10-20 |
PL161165B1 (pl) | 1993-05-31 |
AU8832491A (en) | 1992-04-30 |
DK541987A (da) | 1988-04-17 |
CN87107837A (zh) | 1988-12-21 |
LTIP1794A (en) | 1995-08-25 |
PL161448B1 (pl) | 1993-06-30 |
EP0265785A3 (en) | 1989-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL84154A0 (en) | Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same | |
GB2181435B (en) | Recombinant lav/htlv virus and vaccines | |
FR2647808B1 (fr) | Poxvirus recombinant et vaccin contre le virus de l'herpes contenant ce poxvirus | |
IT1164858B (it) | Procedimento per la preparazione di vaccini a base di virus con proteine superficiali ricombinanti e prodotto ottenuto | |
DE3855947D1 (de) | Peptide mit den immunologischen Eigenschaften von HIV-2 | |
IL80895A (en) | Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-2 and vaccine composition and diagnostic reagent comprising it | |
NZ211880A (en) | Immunogenic, leukemia-associated viral proteins and vaccines | |
ZA862812B (en) | Antigens related to envelope glycoprotein of the virus of aids,methods of obtaining these antigens and means employed in these methods | |
SG49876A1 (en) | Recombinant avipox virus, the culture of cells infected with this virus and vaccines for poultry derived from this virus | |
GB2264949B (en) | Measles virus recombinant poxvirus vaccine | |
PT85137A (en) | T and b cell epitopes of the pre-s region of hepatitis b virus surface antigen | |
EP0298633A3 (en) | Synthetic polypeptides | |
AR244808A1 (es) | Procedimiento para la preparacion de un fragmento de inmunointerferon recombinante homogeneo,preparacion de un microorganismo tipo e.colo,plasmido y microorganismo transformado con dicho plasmido | |
ZA89862B (en) | Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1 | |
DK720588A (da) | Forbindelser til anvendelse ved behandling eller forebyggelse af human-immundefektvirus-(hiv)-infektion, og farmaceutiske praeparater indeholdende samme | |
NZ224393A (en) | Recombinant hiv envelope proteins and uses thereof | |
IL81920A (en) | Vaccines comprising an antigen and interferon-ypsilon and their preparation | |
ZA876168B (en) | Human low fc epsilon-receptor,the isolation,the recombinant preparation and purification thereof | |
ZA893085B (en) | Human immunodeficiency virus(hiv)env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals | |
IL85204A0 (en) | Recombinant human interferon beta2,its preparation and pharmaceutical compositions comprising it | |
IL109078A0 (en) | Vaccines and immunoassays for acquired immune deficiency syndrome using a recombinant virus that expresses an envelope or gag hiv protein or protein or peptide products thereof | |
Fisher | Natalia Goncharova and Franz Marc: kindred spirits of the new art | |
GB8628496D0 (en) | Recombinant human adenovirus vaccines | |
ZA874498B (en) | T and b cell epitopes of the pre-s region of hepatitis b virus surface antigen | |
IE860983L (en) | Antigens related to envelope glycoprotein of the virus of¹aids |